Clinical Trial: Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Opiate Withdrawal Syndrome
Study Type: INTERVENTIONAL
Official Title: Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
Brief Summary:
A placebo-controlled trial in which male and female outpatients with an opioid use disorder who express interest in extended-release injectable naltrexone (XR-NTX) are randomized 1:1 to lofexidine/pregabalin or lofexidine/pregabalin placebo for withdrawal management and offered XR-NTX if after completing withdrawal.
Read more